Non-current inventories
Breakdown
Segments
VibativView metric
KristaloseView metric
VaprisolView metric
SancusoView metric
AcetadoteView metric
IfetrobanView metric
CaldolorView metric
Study DrugView metric
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Vibativ | $6.78M | $6.23M | $6.18M | $5.36M | $4.98M | $4.71M | $4.88M | $5.56M |
| Kristalose | $2.84M | $2.85M | $2.67M | $2.42M | $2.58M | $2.36M | $2.26M | $2.26M |
| Vaprisol | $1.17M | $1.17M | $1.17M | $1.17M | $1.17M | $1.17M | $1.17M | $1.17M |
| Sancuso | $536.24K | $626.88K | $458.68K | $384.91K | $326.12K | $285.15K | $656.67K | $615.87K |
| Caldolor | $98.27K | $54.32K | $77.38K | $178.13K | $162.89K | $118.22K | $112.76K | $95.14K |
| Ifetroban | $203.38K | $203.38K | $166.92K | $150.4K | $65.27K | $65.27K | $40.88K | $40.88K |
| Acetadote | $28.65K | $31.52K | $23.92K | $27.11K | $0 | $69.62K | $24.15K | $23.14K |
| Study Drug | — | — | $166.92K | — | — | — | $40.88K | — |
| Total | $11.87M | $11.83M | $11.01M | $9.94M | $9.53M | $9.18M | $9.25M | $9.88M |